BUMC Transgender Medicine Research Group
Transgender individuals have unique healthcare needs, particularly those who elect to receive hormone therapy and/or gender confirmation surgery. However to-date, very little research has been conducted on important health topics for transgender individuals that genuinely addresses their healthcare concerns and outcomes.
Joshua D. Safer, M.D., FACP, Director, Endocrinology Fellowship Training Program is engaged in clinical research to address this critical lack of knowledge on medical topics regarding transgender-identified individuals.
Our research emphasis is on improving the current medical knowledge on health topics that specifically impact the transgender community, with the goal of continually improving the health and outcomes of transgender individuals who receive medical care. Our BUMC Transgender Research Group affirms the right of all individuals to be able to discuss their health concerns with practitioners who are knowledgeable and respectful towards a patient’s unique, identity-specific needs.
Click below for more information on current published BUMC-connected research in the below topics:
– Clinical transgender health care
- Gardner IH, Safer JD. Progress on the road to better medical care for transgender patients. Curr Opin Endocrinol Diabetes Obes 2013;20(6):553-558. PMID 24468757
- Weinand JD, Safer JD. Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocr 2015; 2:55-60
- Myers SC, Safer JD. Increased rates of smoking cessation observed among transgender women receiving hormone treatment. Endocr Pract 2017
- Stevenson Mary O., Wixon Naomi, and Safer Joshua D. Transgender Health. October 2016, 1(1): 202-204. doi:10.1089/trgh.2016.0022
– Evidence of biological nature of gender identity
- Saraswat A, Weinand JD, Safer JD. Evidence supporting the biological nature of gender identity. Endocr Pract 2015; 21(2):199-204. PMID 25667367
- Safer JD. The recognition that gender identity is biological complicates some previously settled clinical decision making. AACE Clinical Case Rep 2017
– Improving medical education for medical trainees
- Safer JD, Pearce EN. A simple curriculum content change increased medical student comfort with transgender medicine. Endocr Pract 2013;19(4):633-637. PMID 23425656
- Thomas DD, Safer JD. A simple intervention raised resident-physician willingness to assist transgender patients seeking hormone therapy. Endocr Pract 2015;21(10):1134-42. PMID 26151424
- Eriksson SES, Safer JD. Evidence-based curricular content improves student knowledge and changes attitudes towards transgender medicine. Endocr Pract 2016;22(7):837-841. PMID 27042742
- Chan B, Skocylas R, Safer JD. Gaps in transgender medicine content identified among Canadian medical school curricula. Transgender Health 2016;1(1):142-150.
- Safer JD. The large gaps in transgender medical knowledge among providers must be measured and addressed. Endocr Pract 2016;22(7):902-903. PMID 27214166
– Research gaps for transgender health care
- Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, Sevelius J. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes 2016; 23(2):168-171. PMID 26910276
- Feldman J, Brown GR, Deutsch MB, Hembree W, Meyer W, Meyer-Bahlburg HFL, Tangpricha V, T’Sjoen G, Safer JD. Priorities for transgender medical and healthcare research. Curr Opin Endocrinol Diabetes Obes 2016; 23(2):180-187. PMID 26825469
- Reisner SL, Deutsch MB, Bhasin S, Bockting W, Brown GR, Feldman J, Garofalo R, Kreukels B, Radix A, Safer JD, Tangpricha V, T’Sjoen G, Goodman M. Advancing Methods for U.S. Transgender Health Research. Curr Opin Endocrinol Diabetes Obes 2016; 23(2):198-207. PMID 26845331
Additionally, our work includes the development of a Transgender Health Registry at BMC. All transgender-identified individuals who have had hormone therapy or other transgender health care management at Boston Medical Center (BMC) who give consent to participate will have their name, date of birth, and medical record number recorded in a registry. By compiling a list of those treated here at BMC, researchers (approved by the Institutional Review Board) will be able to access more complete data when studying the long term effects of hormonal treatment and/or other aspects of care. It is our hope that by establishing the first BMC registry of Transgender Health, we will be able to better serve individuals who identify as transgender within our community both now and in the future.